NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared Diagnostic Hybrids' respiratory viral identification kit for use in the US, the company said Tuesday.

Diagnostic Hybrids, which is based in Athens, Ohio, said that the FDA has cleared its D3 Fastpoint L-DFA RSV/MPV Identification kit.

The kit allows for the identification of respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in less than 25 minutes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.